Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep346 | Diabetes (pathiophysiology & epitemiology) | ECE2015

Association between +276 G>T polymorphism of the adiponectin gene (ADIPOQ) and insulin resistance in Ukrainian patients with type 2 diabetes mellitus (T2DM)

Karachentsev Yuri , Kravchun Nonna , Gorshunska Maryanna , Atramentova Lubov , Krasova Nataliia , Tyzhnenko Tatyana , Leshchenko Zhanna , Gladkih Alexander , Pochernyaev Artyom , Opaleiko Yuliia , Plohotnichenko Olga , Poltorak Victoria

Variants of ADIPOQ have been inconsistently associated with adiponectin level in diverse populations. We explored association of single nucleotide polymorphism (SNP) in the ADIPOQ (+276 G>T, rs1501299) with circulating total adiponectin and insulin resistance (IR) in Ukrainian T2DM cohort.Materials and methods: 544 T2DM patients (M/F: 241/303, age 56.3±0.4 years, diabetes duration 7.8±1.0 years, BMI 31.7&...

ea0038p147 | Neoplasia, cancer and late effects | SFEBES2015

Steroid sulphatase and G-protein coupled oestrogen receptor in human colorectal cancer: correlation with late-stage disease and potential therapeutic targets

Rahman Habibur , Gilligan Lorna , Hewitt Anne-Marie , Morton Dion , Foster Paul

Steroid sulphatase (STS) liberates sulphated oestrogens into their active forms. In the colon, evidence suggests that although initially pro-apoptotic in healthy mucosa, once malignancy occurs, oestrogens may stimulate colorectal cancer (CRC) proliferation. Moreover, greater intratumoural oestrogen synthesis is negatively associated with survival outcomes in CRC patients. However, little is known about oestrogen metabolism pathways in CRC, and whether alterations in local oest...

ea0037ep1126 | Endocrine tumours | ECE2015

Oestrogen metabolism by steroid sulphatase and 17β-hydroxysteroid dehydrogenases promotes colorectal cancer proliferation via the G-protein coupled oestrogen receptor

Gilligan Lorna , Rahman Habibur , Hewitt Anne-Marie , Taylor Angela , Morton Dion , Foster Paul

Colorectal cancer (CRC) is the third most common cancer worldwide with incidence expected to rise. Although not traditionally viewed as a hormonal cancer, evidence suggests peripheral synthesis of active oestrogens worsens prognosis. Oestrogen metabolising enzymes include steroid sulphatase (STS), which desulphates oestrogens into their active forms, and 17β-hydroxysteroid dehydrogenases (17βHSD), which are estrogen oxidoreductase enzymes. We have previously shown ST...

ea0070aep1021 | Hot topics (including COVID-19) | ECE2020

Association of osteoprotegerin 1181G > C and 245T > G polymorphisms and diabetic Charcot osteoarthropathy in Egyptian patients

Zakaria Basma , Gawish Hanan , Elfarahaty Reham , Tarshoby Manal

Aim: Egypt is among the world’s top 10 countries in terms of the highest number of people with diabetes. Charcot foot is a serious complication that affect bones, joints, and soft tissues of the foot or ankle. Although the etiology is linked to different inflammatory markers, yet not clear. Recently, an association between two polymorphisms (1181G > C and 245T > G) of the osteoprotegerin (OPG) gene and Charcot was suggested. The aim of this study was to explore p...

ea0081p455 | Reproductive and Developmental Endocrinology | ECE2022

Analysis of follicle-stimulating hormone receptor (FSHR)/g-protein coupled estrogen receptor (GPER) complex internalization through early and late endosomes

Lazzaretti Clara , Casadei Garofani Beatrice , Paradiso Elia , D'Alessandro Sara , Sperduti Samantha , Roy Neena , Mascolo Elisa , Baschieri Lara , Anzivino Claudia , Simoni Manuela , Casarini Livio

Introduction: Follicle-stimulating hormone (FSH) is a glycoprotein that support reproduction by regulating ovarian follicular growth and development. Recent studies demonstrated that proliferative signals mediating folliculogenesis are mediated by the G protein-coupled estrogen receptor (GPER) expressed in ovarian tissues throughout the follicular phase. In granulosa cells, GPER forms heteromers with FSHR, reprogramming cAMP-induced death signals to AKT-dependent, anti-apoptot...

ea0063p645 | Interdisciplinary Endocrinology 1 | ECE2019

Demonstration of follicle-stimulating hormone receptor (FSHR) and G protein-coupled estrogen receptor (GPER) heterodimerization by bioluminescence resonance energy transfer (BRET)

Lazzaretti Clara , Paradiso Elia , Riccetti Laura , Sperduti Samantha , Brigante Giulia , Poti Francesco , Fanelli Francesca , Simoni Manuela , Hanyaloglu Aylin Carla , Casarini Livio

During the menstrual cycle, selection of the dominant follicle is characterized by changes of gonadotropin and steroid hormone receptor expression. We aim to evaluate whether co-existing follicle-stimulating hormone receptor (FSHR) and G protein-coupled estrogen receptor (GPER) form heterodimers, suggesting their role in ovarian follicle selection. FSHR-GPER dimerization was evaluated in transfected HEK293 cells in vitro by bioluminescence resonance energy transfer (B...

ea0070oc9.4 | Reproductive and Developmental Endocrinology | ECE2020

Demonstration of follicle-stimulating hormone receptor and G protein-coupled estrogen receptor heteromers in vitro via BRET and super-resolution imaging

Lazzaretti Clara , Sayers Niamh , Paradiso Elia , Sperduti Samantha , Fanelli Francesca , Simoni Manuela , Hanyaloglu Aylin , Casarini Livio

Introduction: The developmental stages of the ovarian follicle are characterized by changes of gonadotropin and steroid hormone receptor expression and their potential interactions on the surface of granulosa cells. In this study in vitro, we aim to evaluate whether the co-existing follicle-stimulating hormone receptor (FSHR) and G protein-coupled estrogen receptor (GPER) form heteromers, which may play role in selecting the dominant ovarian follicle.<p class="abs...

ea0086ec1.4 | Clinical Endocrinology Trust Best Abstract Basic | SFEBES2022

Characterising the G-protein signalling mechanisms activated by short chain fatty acids in human enteroendocrine cells which mediate production and release of the anorectic gut hormones peptide YY (PYY) and glucagon-like peptide-1 (GLP-1)

Hirdaramani Aanya , Frost Gary , Hanyaloglu Aylin

The anorectic gut hormones glucagon-like peptide-1 (GLP-1) and Peptide YY (PYY) are secreted by enteroendocrine L cells in response to short chain fatty acids (SCFAs) produced by gut microbiota following dietary fibre consumption. SCFAs, acetate, propionate and butyrate, activate the G protein-coupled receptors Free Fatty Acid Receptor 2 and 3 (FFAR2, FFAR3). Increasing intestinal levels of propionate can prevent weight gain in overweight adults. In rodents, FFAR2-mediated gut...

ea0063p44 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Comparative study between autoimmune metaplastic atrophic gastritis (AMAG) and type 1 gastric neuroendocrine tumors (G-NETs) in Hospital Clínico San Carlos (HCSC), Madrid

Ramos Elvira , Vargas-Zuniga Ignacio , Barrio Elvira , Suarez Pablo , Pazos Mario , Pallares Raquel , Aldama Paula , De La Torre Nuria Garcia , Sevilla Concepcion , Diaz Jose Angel

Introduction: Type 1 Gastric neuroendocrine tumors account for 70 to 80 percent of all gastric neuroendocrine tumors (G-NETs) and they are found more commonly in older adults, particularly women. They are associated with autoimmune metaplastic atrophic gastritis (AMAG) with or without pernicious anemia. Endoscopically, they are usually smaller than 1 cm and often multiple. These tumors usually present a non-aggressive evolution. Our goal is to approach the presence of risk fac...

ea0028p356 | Thyroid | SFEBES2012

The long-term management of thyrotoxicosis with antithyroid drugs

Boregowda Kusuma , Stephens Jeffrey , Price David

Little has been published on the long-term management of thyrotoxicosis with antithyroid drugs (ATDs). We analysed 376 thyrotoxic subjects on the Morriston database since 2002. 170 had Graves’ disease, 181 toxic multinodular goitre (TMNG); in 25 the diagnosis was not recorded. When euthyroid subjects were requested to have annual thyroid function testing 42 (11%) had died. 111(30%) did not have TFT’s done in last two years. 135 graves’s cases were given ATDs whi...